U.S., Aug. 26 -- ClinicalTrials.gov registry received information related to the study (NCT07784894) titled 'A Study to Investigate the Repeat-dose Pharmacokinetics of a Combined Oral Contraceptive When Given Alone and in Combination With Ganfeborole in Female Participants of Non-childbearing Potential' on Aug. 21.
Brief Summary: This study is designed to assess the pharmacokinetics (PK), safety, and tolerability of Ganfeborole and Microgynon, an oral contraceptive containing ethinylestradiol (EE) and levonorgestrel (LNG), when Microgynon is administered alone and in combination with Ganfeborole in healthy female participants of non-childbearing potential.
Study Start Date: Sept. 01
Study Type: INTERVENTIONAL
Condition:
Tuberculosis
I...